Archive - February 2022
Lupin Announces FDA Approval of Supplemental New Drug Application for Solosec (secnidazole) in Adolescents for both the Treatment of Bacterial Vaginosis in Females and Trichomoniasis
Vaccinated Less Likely To Suffer Long COVID Symptoms Than Unvaccinated, Study Says
MSD and Curve Therapeutics agree on deal potentially worth $1.7bn
AZ’s Saphnelo receives EU approval for systemic lupus erythematosus
Alexion and UK patient advocacy groups launch video campaign
New medicine for patients with systemic lupus erythematosus
FDA year in review: 50 novel drug approvals and more
First Woman Reported Cured Of HIV After Stem Cell Transplant